Coherus BioSciences, Inc. (CHRS)
NASDAQ
Market Cap
$190.45M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
531 of 809
Rank in Industry
290 of 445
Largest Insider Buys in Sector
CHRS Stock Price History Chart
CHRS Stock Performance
About Coherus BioSciences, Inc.
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Insider Activity of Coherus BioSciences, Inc.
Over the last 12 months, insiders at Coherus BioSciences, Inc. have bought $0 and sold $449,770 worth of Coherus BioSciences, Inc. stock.
On average, over the past 5 years, insiders at Coherus BioSciences, Inc. have bought $49,668 and sold $17.83M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,700 shares for transaction amount of $49,668 was made by Stilwell McDavid (Chief Financial Officer) on 2021‑06‑09.
List of Insider Buy and Sell Transactions, Coherus BioSciences, Inc.
| 2023-11-22 | Sale | Lanfear Dennis M | President & CEO | 223,100 0.2098% | $2.02 | $449,770 | +11.07% | |
| 2021-10-15 | Sale | Stilwell McDavid | Chief Financial Officer | 3,507 0.0045% | $16.80 | $58,919 | -30.65% | |
| 2021-09-29 | Sale | HEALY JAMES | director | 286,076 0.3546% | $16.12 | $4.61M | -26.09% | |
| 2021-09-28 | Sale | HEALY JAMES | director | 48,329 0.0622% | $17.17 | $829,809 | -27.59% | |
| 2021-09-27 | Sale | HEALY JAMES | director | 100,150 0.1287% | $18.06 | $1.81M | -30.86% | |
| 2021-06-09 | Stilwell McDavid | Chief Financial Officer | 3,700 0.0049% | $13.42 | $49,668 | +0.96% | ||
| 2021-06-08 | Sale | Lanfear Dennis M | President & CEO | 31,054 0.0411% | $13.56 | $421,229 | +0.59% | |
| 2021-03-09 | Sale | Vexler Vladimir | Chief Scientific Officer | 114,240 0.1583% | $16.25 | $1.86M | -9.44% | |
| 2021-03-05 | Sale | Anicetti Vincent R | Chief Operating Officer | 26,649 0.0357% | $15.46 | $412,065 | -7.55% | |
| 2021-02-17 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,488 0.0034% | $17.45 | $43,418 | -13.71% | |
| 2021-02-01 | Sale | Viret Jean-Frederic | Chief Financial Officer | 7,402 0.0124% | $21.55 | $159,513 | -13.35% | |
| 2021-01-25 | Sale | Viret Jean-Frederic | Chief Financial Officer | 46,144 0.0647% | $19.95 | $920,736 | -21.18% | |
| 2021-01-19 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,500 0.0034% | $17.94 | $44,852 | -13.26% | |
| 2020-12-17 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,500 0.0034% | $17.51 | $43,780 | -10.94% | |
| 2020-12-10 | Sale | Vexler Vladimir | Chief Scientific Officer | 17,626 0.0246% | $18.05 | $318,066 | -11.68% | |
| 2020-12-09 | Sale | Vexler Vladimir | Chief Scientific Officer | 49,512 0.0685% | $18.24 | $903,084 | -13.28% | |
| 2020-12-07 | Sale | Anicetti Vincent R | Chief Operating Officer | 8,791 0.0122% | $18.42 | $161,896 | -13.80% | |
| 2020-12-04 | Sale | Anicetti Vincent R | Chief Operating Officer | 49,000 0.0675% | $18.85 | $923,694 | -16.42% | |
| 2020-12-03 | Sale | Anicetti Vincent R | Chief Operating Officer | 49,756 0.0692% | $18.67 | $929,079 | -14.87% | |
| 2020-11-18 | Sale | Anicetti Vincent R | Chief Operating Officer | 4,283 0.006% | $18.00 | $77,094 | -11.09% |
Insider Historical Profitability
55.38%
| Lanfear Dennis M | President & CEO | 731693 0.657% | $1.66 | 0 | 10 | |
| LILLY ELI & CO | 3042019 2.7316% | $1.66 | 1 | 0 | +82.59% | |
| FMR LLC | 361594 0.3247% | $1.66 | 0 | 3 | ||
| Troendle August J. | director | 268428 0.241% | $1.66 | 0 | 3 | |
| Richards Christos | director | 63836 0.0573% | $1.66 | 0 | 2 | |
| Viret Jean-Frederic | Chief Financial Officer | 61295 0.055% | $1.66 | 0 | 24 | |
| Anicetti Vincent R | Chief Operating Officer | 53402 0.048% | $1.66 | 0 | 25 | |
| Vexler Vladimir | Chief Scientific Officer | 53386 0.0479% | $1.66 | 0 | 3 | |
| Herman Alan C. | Chief Scientific Officer | 49651 0.0446% | $1.66 | 0 | 26 | |
| FINCK BARBARA K | Chief Medical Officer | 37043 0.0333% | $1.66 | 0 | 5 | |
| Stilwell McDavid | Chief Financial Officer | 31611 0.0284% | $1.66 | 1 | 1 | +0.96% |
| HEALY JAMES | director | 0 0% | $1.66 | 1 | 8 | +82.59% |
| Szela Mary T | director | 0 0% | $1.66 | 0 | 1 | |
| Wahlstrom Mats | director | 0 0% | $1.66 | 0 | 7 | |
| Watler Peter K. | Chief Technical Officer | 0 0% | $1.66 | 0 | 7 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $26.84M | 9.79 | 11.23M | -6.99% | -$2.02M | <0.01 | |
| Helm Capital Management LLC | $24.86M | 9.07 | 10.4M | +2,531.53% | +$23.91M | 0.74 | |
| The Vanguard Group | $24.09M | 8.79 | 10.08M | -2.68% | -$664,080.62 | <0.0001 | |
| Temasek Holdings | $17.64M | 6.43 | 7.38M | 0% | +$0 | 0.1 | |
| Kohlberg Kravis Roberts | $7.26M | 2.65 | 3.04M | 0% | +$0 | 0.22 | |
| Citadel Advisors LLC | $6.55M | 2.39 | 2.74M | +37.97% | +$1.8M | <0.01 | |
| Morgan Stanley | $6.37M | 2.32 | 2.66M | +28.71% | +$1.42M | <0.0001 | |
| Bank of America | $5.8M | 2.12 | 2.43M | +14.56% | +$737,126.09 | <0.01 | |
| Geode Capital Management | $5.27M | 1.92 | 2.2M | +5.87% | +$291,833.09 | <0.0001 | |
| Barclays | $4.94M | 1.8 | 2.07M | -40.73% | -$3.39M | <0.01 | |
| State Street | $4.77M | 1.74 | 2M | -3.32% | -$163,925.33 | <0.0001 | |
| C Worldwide Group Holding A S | $4.61M | 1.68 | 1.93M | 0% | +$0 | 0.05 | |
| Goldman Sachs | $4.1M | 1.49 | 1.71M | +104.71% | +$2.1M | <0.01 | |
| Two Sigma | $3.49M | 1.27 | 1.46M | +0.8% | +$27,869.79 | 0.01 | |
| Millennium Management LLC | $3.01M | 1.1 | 1.26M | -55.76% | -$3.79M | <0.01 | |
| Disciplined Growth Investors Inc Mn | $3M | 1.1 | 1.26M | +7.65% | +$213,211.87 | 0.06 | |
| Tejara Capital Ltd | $2.52M | 0.92 | 1.06M | New | +$2.52M | 0.86 | |
| PEREGRINE CAPITAL MANAGEMENT INC | $2.43M | 0.89 | 1.02M | -6.74% | -$175,679.31 | 0.07 | |
| Cm Management Llc | $2.39M | 0.87 | 1M | +21.36% | +$420,640.00 | 0.11 | |
| Alphacentric Advisors Llc | $2.39M | 0.87 | 1M | 0% | +$0 | 1.52 | |
| Northern Trust | $2.2M | 0.8 | 921,641 | -4.59% | -$106,060.98 | <0.0001 | |
| Macquarie Group | $2.15M | 0.78 | 899,999 | +38.46% | +$597,500.66 | <0.01 | |
| Clearline Capital LP | $1.87M | 0.68 | 784,449 | New | +$1.87M | 0.19 | |
| Hudson Bay Capital Management LP | $1.67M | 0.61 | 700,000 | +19.66% | +$274,850.00 | 0.02 | |
| Charles Schwab | $1.65M | 0.6 | 689,126 | -10.23% | -$187,784.67 | <0.0001 | |
| Brandywine Global Investment Management | $1.33M | 0.49 | 555,945 | 0% | +$0 | 0.01 | |
| Woodline Partners LP | $1.28M | 0.47 | 535,439 | +7.09% | +$84,699.20 | 0.01 | |
| Citigroup | $1.23M | 0.45 | 516,716 | +38.23% | +$341,552.44 | <0.01 | |
| Susquehanna International Group | $935,358.00 | 0.34 | 391,363 | -49.59% | -$919,956.83 | <0.01 | |
| LAZARD ASSET MANAGEMENT LLC | $926,000.00 | 0.34 | 387,700 | +2,794.8% | +$894,011.56 | <0.01 | |
| Jane Street Capital | $864,133.00 | 0.32 | 361,562 | -34.72% | -$459,678.16 | <0.01 | |
| SEI Investments Company | $853,177.00 | 0.31 | 356,978 | -2.31% | -$20,181.15 | <0.01 | |
| Wellington Management Company | $815,473.00 | 0.3 | 341,202 | New | +$815,473.00 | <0.0001 | |
| Bridge City Capital | $753,768.00 | 0.28 | 315,384 | +0.78% | +$5,855.50 | 0.28 | |
| BNY Mellon | $738,517.00 | 0.27 | 309,003 | -12.78% | -$108,190.49 | <0.0001 | |
| Birchview Capital Lp | $645,300.00 | 0.24 | 270,000 | +145.46% | +$382,400.00 | 0.04 | |
| JPMorgan Chase | $542,719.00 | 0.2 | 227,079 | -47.88% | -$498,523.10 | <0.0001 | |
| Group One Trading | $520,162.00 | 0.19 | 217,641 | -36.26% | -$295,920.25 | 0.02 | |
| Two Sigma Advisers LP | $494,969.00 | 0.18 | 207,100 | -11.53% | -$64,530.00 | <0.01 | |
| Los Angeles Capital Management LLC | $468,942.00 | 0.17 | 196,210 | +43.41% | +$141,942.13 | <0.01 | |
| Jefferies Financial Group | $469,934.00 | 0.17 | 196,625 | +135.13% | +$270,070.14 | 0.01 | |
| Pennant Capital Management Llc | $401,759.00 | 0.15 | 168,100 | 0% | +$0 | 0.06 | |
| New York Life Investment Management Llc | $370,536.00 | 0.14 | 155,036 | +210.34% | +$251,138.78 | <0.01 | |
| Renaissance Technologies | $364,000.00 | 0.13 | 152,328 | New | +$364,000.00 | <0.01 | |
| Marshall Wace | $362,236.00 | 0.13 | 151,563 | +29.34% | +$82,175.47 | <0.0001 | |
| AllianceBernstein | $350,135.00 | 0.13 | 146,500 | -6.09% | -$22,705.00 | <0.0001 | |
| Susquehanna Fundamental Investments Llc | $349,492.00 | 0.13 | 146,231 | New | +$349,492.00 | 0.02 | |
| RhumbLine Advisers | $309,882.00 | 0.11 | 129,663 | +4% | +$11,913.67 | <0.0001 | |
| Deutsche Bank | $299,976.00 | 0.11 | 125,513 | -88.92% | -$2.41M | <0.0001 | |
| UBS | $291,269.00 | 0.11 | 121,870 | -15.56% | -$53,669.79 | <0.0001 |